Frequency and risk factors of potential drug interactions in breast cancer patients.
dc.authorid | harputluoglu, hakan/0000-0001-8537-5941 | |
dc.authorid | Elkıran, Emin Tamer/0000-0001-6681-7249 | |
dc.authorwosid | harputluoglu, hakan/ABI-6451-2020 | |
dc.authorwosid | Elkıran, Emin Tamer/ABI-8192-2020 | |
dc.contributor.author | Acar, Fatma | |
dc.contributor.author | Dursun, Brahim Hakki | |
dc.contributor.author | Harputluoglu, Hakan | |
dc.contributor.author | Yigit, Ali | |
dc.contributor.author | Kilic, Mehmet Salih | |
dc.contributor.author | Elkiran, Emin Tamer | |
dc.date.accessioned | 2024-08-04T20:58:52Z | |
dc.date.available | 2024-08-04T20:58:52Z | |
dc.date.issued | 2014 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description | 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 30-JUN 03, 2014 -- Chicago, IL | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.identifier.doi | 10.1200/jco.2014.32.15_suppl.e17669 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 15 | en_US |
dc.identifier.uri | https://doi.org/10.1200/jco.2014.32.15_suppl.e17669 | |
dc.identifier.uri | https://hdl.handle.net/11616/103235 | |
dc.identifier.volume | 32 | en_US |
dc.identifier.wos | WOS:000358613201120 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Frequency and risk factors of potential drug interactions in breast cancer patients. | en_US |
dc.type | Conference Object | en_US |